Biotech Outsourcing Strategies is one of the key-events of the pharma branche. BOS Manchester 2022 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.

The scope of BOS MANCHESTER 2022 will be pharmaceutical Discovery Outsourcing and pharmaceutical CMC Outsourcing (primarily development phase). Both small molecules and biologics are included in this scope.

Neil Jones, chief commercial officer at Aenova Group, is one of the panel session participants on the topic of "Trends Shaping Pharmaceutical Outsourcing" on 17 November 2022.

The Aenova Group is a leading global contract manufacturer and development services provider for the pharmaceutical and healthcare industry. Our services include end-to-end manufacturing and development of all dosage forms and potency levels (ranging from nutraceuticals to high-potents) out of 15 sites in Europe and the US.

With our comprehensive know-how, many years of experience, well-trained staff of 4,200 employess, innovative technologies and highest quality standards we are a reliable, long-term partner to pharmaceutical and consumer health care customers around the world, both in the human and veterinary healthcare market.

For more information, a program overview and registration see BOS Manchester 2022 website.